Capstone Holding Corp. (CAPS) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
High 0.19 at 5:00 am ET, low 0.17 at 2:30 pm ET.
Capstone Holding Corp.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Wholesale-Lumber & Other Construction Materials
No case yet. It builds on the next filing, report or 13F period.
Capstone Holding Corp. has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 5030, Wholesale-Lumber & Other Construction Materials, from each company's own filings. Largest first.
8 managers report a position worth $53,269 between them, and 4 of them hold 80% of it.
tall tick = annual report · 1 on record
CAPS (Capstone Holding Corp.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.